Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideo Kato is active.

Publication


Featured researches published by Hideo Kato.


Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology | 2000

The house musk shrew (Suncus murinus): a unique animal with extremely low level of expression of mRNAs for CYP3A and flavin-containing monooxygenase

Taisei Mushiroda; Tsuyoshi Yokoi; Kunio Ito; Ken-ichi Nunoya; Tetsuya Nakagawa; Megumi Kubota; Eiji Takahara; Osamu Nagata; Hideo Kato; Tetsuya Kamataki

Expression of drug-metabolizing enzymes including cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) in various tissues of Suncus murinus (Suncus) were examined. Northern blot analysis showed that mRNAs hybridizable with cDNAs for rat CYP1A2, human CYP2A6, rat CYP2B1, human CYP2C8, human CYP2D6, rat CYP2E1, human CYP3A4 and rat CYP4A1 were expressed in various tissues from Suncus. The mRNA level of CYP2A in the Suncus lung was very high. Furthermore, it was found that the level of CYP2A mRNA in the Suncus lung was higher compared to the Suncus liver. The expression level of mRNA hybridizable with cDNA for human CYP3A4 was very low. The presence of CYP3A gene in Suncus was proven by the induction of the CYP with dexamethasone. Very low expression levels of mRNAs hybridizable with cDNAs for rat FMO1, rat FMO2, rat FMO3 and rat FMO5 were also seen in Suncus liver. No apparent hybridization band appeared when human FMO4 cDNA was used as a probe. The hepatic expression of mRNAs hybridizable with cDNAs for UDP-glucuronosyltransferase 1*6, aryl sulfotransferase, glutathione S-transferase 1, carboxyesterase and microsomal epoxide hydrolase in the Suncus were observed. These results indicate that the Suncus is a unique animal species in that mRNAs for CYP3A and FMO are expressed at very low levels.


Drug Metabolism and Disposition | 1988

Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.

E Okezaki; Tetsuya Terasaki; M Nakamura; Osamu Nagata; Hideo Kato; Akira Tsuji


Journal of Pharmacology and Experimental Therapeutics | 1999

Efflux Transport of a New Quinolone Antibacterial Agent, HSR-903, across the Blood-Brain Barrier

Mitsuo Murata; Ikumi Tamai; Hiroshi Kato; Osamu Nagata; Hideo Kato; Akira Tsuji


Drug Metabolism and Disposition | 1998

Hepatobiliary Transport Kinetics of HSR-903, a New Quinolone Antibacterial Agent

Mitsuo Murata; Ikumi Tamai; Yoshimichi Sai; Osamu Nagata; Hideo Kato; Yuichi Sugiyama; Akira Tsuji


The American Journal of Medicine | 1988

Wegener's granulomatosis: diagnosis by transbronchial lung biopsy, evaluation by gallium scintigraphy and treatment with sulfamethoxazole/trimethoprim

Kazumi Yuasa; Manabu Tokitsu; Hajime Goto; Hideo Kato; Kaoru Shimada


Journal of Pharmacology and Experimental Therapeutics | 1999

Carrier-Mediated Lung Distribution of HSR-903, a New Quinolone Antibacterial Agent

Mitsuo Murata; Ikumi Tamai; Yoshimichi Sai; Osamu Nagata; Hideo Kato; Akira Tsuji


Journal of pharmacobio-dynamics | 1988

Entry of the New Quinolone Antibacterial Agents of Ofloxacin and NY-198 into the Central Nervous System in Rats

Hitoshi Sato; Eiichi Okezaki; Setsuko Yamamoto; Osamu Nagata; Hideo Kato; Akira Tsuji


Drug Metabolism and Disposition | 1990

Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate.

Osamu Nagata; Mitsuo Murata; Hideo Kato; Tetsuya Terasaki; Hitoshi Sato; Akira Tsuji


Nihon Kikan Shokudoka Gakkai Kaiho | 1978

Transbronchial Bacteriological Culture Study Using the Flexible Fiberoptic Bronchoscope

Hideo Kato; Yoshimitsu Fukuhara; Keimei Mashimo; Shingo Matsushima; Taketoshi Saito


Chest | 1974

Experimental study for rapid sterilization of the flexible fiberoptic bronchoscope.

Hideo Kato; Shingo Matsushima

Collaboration


Dive into the Hideo Kato's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kaoru Shimada

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge